|
TOP STORY |
Human Muscle Stem Cell Therapy Gets Help from Zebrafish Scientists have discovered that the same chemicals that stimulate muscle development in zebrafish can also be used to differentiate human stem cells into muscle cells in the laboratory, an historically challenging task that, now overcome, makes muscle cell therapy a more realistic clinical possibility. [Press release from the Harvard Stem Cell Institute discussing research published in Cell .] Press Release | Abstract |
PUBLICATIONS (Ranked by impact factor of the journal) |
Transplantation of Human Islets without Immunosuppression The authors present the clinical success of using a bioartificial pancreas for the transplantation of insulin-producing islets without affecting the immune system. In a patient with long-standing type-1 diabetes, they could demonstrate persistent graft function and regulated insulin secretion without the need for immune-modulating medication. [Proc Natl Acad Sci USA] Abstract | Press Release Short-Term Sonic-Hedgehog Gene Therapy to Mitigate Myelosuppression in Highly Irradiated Monkeys: Hype or Reality? Clinical-Grade Human Neural Stem Cells Promote Reparative Neovascularization in Mouse Models of Hindlimb Ischemia Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation. A Study of the MPN-Subcommittee of the CMWP of the EBMT Risk of Seizures in Children Receiving Busulphan Containing Regimens for Stem Cell Transplantation EBV-Associated Post-Transplant Lymphoproliferative Disorder Following In Vivo T-Cell-Depleted Allogeneic Transplantation: Clinical Features, Viral Load Correlates and Prognostic Factors in the Rituximab Era Treatment with Placenta-Derived Mesenchymal Stem Cells Mitigates Development of Bronchiolitis Obliterans in a Murine Model Bone Marrow Mesenchymal Stem Cells Protect against Retinal Ganglion Cell Loss in Aged Rats with Glaucoma Intravenous Multipotent Adult Progenitor Cell Therapy Attenuates Activated Microglial/Macrophage Response and Improves Spatial Learning After Traumatic Brain Injury |
REVIEWS |
Current Status and Perspectives on Stem Cell-Based Therapies Undergoing Clinical Trials for Regenerative Medicine: Case Studies This review summarizes key clinical trial data, current and future perspectives on stem cell-based products undergoing clinical trials, based on literature search and author research. [Br Med Bull] Abstract Visit our reviews page to see a complete list of reviews in the cell, gene and immunotherapy research field. |
SCIENCE NEWS |
Mesoblast’s Mesenchymal Precursor Cells Induce Functional Recovery in Ischemic Stroke Model Regenerative medicine company Mesoblast Limited announced positive preclinical trial results which demonstrated that its proprietary Mesenchymal Precursor Cells (MPCs) could improve functional recovery following a stroke. The trial results showed that a single intravenous injection of human MPCs significantly enhanced sensorimotor recovery when administered up to seven days after an ischemic stroke in rats. [Press release from Mesoblast Limited discussing research presented at Neuroscience 2013, San Diego.] Press Release Argos Therapeutics Presents Data Showing Memory T Cell Expansion After Administration of Fully Personalized Immunotherapy Correlates with Overall Survival Benefit in Patients with Metastatic Renal Cell Carcinoma Merck’s Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms and Need for Symptom-Relief Medication in Adults and Children in Pivotal Phase III Study Aduro Announces Presentation on Small-Molecule Immunotherapy Program at SITC Conference |
POLICY |
Report Tallies U.S. Shutdown Costs A new report from the White House’s Office of Management and Budget fills in a few more details on how last month’s 16-day U.S. government shutdown affected research. The 27- page tally of the shutdown’s costs concludes that that disruption cost the government at least $2 billion in lost productivity and helped nudge up the nation’s unemployment rate. [Science Insider] Editorial Republican Plan to Guide NSF Programs Draws Darts, and Befuddlement, From Research Advocates |
BUSINESS |
CureVac Collaborates with the Cancer Research Institute and Ludwig Cancer Research to Enable Clinical Testing of Novel Immunotherapy Treatment Options for Cancer The non-profit Cancer Research Institute and Ludwig Cancer Research, and CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA, announced that they will collaborate to enable clinical testing of novel cancer immunotherapy treatment options. [CureVac]Press Release STEMCELL Technologies Receives Government of Canada Support to Develop New Cell Isolation Technology that Will Enable Advancements in the Study of the Immune Response to HIV and the Development of HIV Vaccines Study Using Stem Cells to Improve Organ Transplantation to Receive $12 Million SDSU Receives $8.5M for Heart Research Cytori Receives $12 Million for the First Installment from the Lorem Vascular Partnership Equity Agreement $100 Million Gift Launches Sanford Stem Cell Clinical Center Cellular Dynamics Receives Formal Notice of Grant Award (NGA) for $16 Million Stem Cell Banking Project The Economist Honors Cancer Immunotherapy Pioneer James Allison |
REGULATORY |
Food and Drug Administration (United States) |
EVENTS |
NEW Danish Stem Cell Society’s 3rd Symposium March 7-8, 2014 Nyborg, Denmark Visit our events page to see a complete list of events in the cell, gene and immunotherapy community. |
SUBSCRIBER TOOLS: | |||
Profile Center | Connexon Publications | Article Submission | Contact Us |